Myeloma Paper of the Day, July 7th, Suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Analysis of ASCT and AL amyloidosis at Mayo (2010-2024) finds a decrease in utilization; recent transplants mainly in patients with suboptimal responses, relapsed/refractory disease, lymphoplasmacytic clones or high BM PCs (MM phenotype).”
Title: From CyBorD to Dara-CyBorD: ASCT Utilization Trends in AL Amyloidosis, A 15-Year Analysis
Authors: Eli Muchtar, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, David Dingli, Taxiarchis V. Kourelis, Wilson I Gonsalves, Nelson Leung, Suzanne R Hayman, Martha Q Lacy, Mustaqeem Siddiqui, Joselle Cook, Nadine Abdallah, Moritz Binder, Saurabh Zanwar, William J Hogan, Rahma Warsame, S. Vincent Rajkumar, Shaji K Kumar, Morie A Gertz
You can read the Full Article in Blood Advances.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023